Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

Tag: MHRA GMP requirements

TGA GMP for Clinical Trials: What Pharma Companies Need to Know

Posted on December 14, 2024 By digi

TGA GMP for Clinical Trials: What Pharma Companies Need to Know Understanding TGA GMP Guidelines for Clinical Trials in Australia Introduction to TGA GMP for Clinical Trials Clinical trials are a cornerstone of pharmaceutical innovation, enabling companies to test the safety, efficacy, and quality of new drugs before they reach the market. In Australia, the…

Read More “TGA GMP for Clinical Trials: What Pharma Companies Need to Know” »

TGA GMP Guidelines

How to Align Schedule M (Revised) GMP Guidelines with Global Standards

Posted on December 14, 2024 By digi

How to Align Schedule M (Revised) GMP Guidelines with Global Standards Steps to Align Schedule M (Revised) GMP Guidelines with Global Pharmaceutical Standards Introduction to Schedule M (Revised) and Global Standards The pharmaceutical industry operates in a highly regulated environment, with stringent guidelines governing manufacturing practices to ensure drug quality and safety. India’s Schedule M…

Read More “How to Align Schedule M (Revised) GMP Guidelines with Global Standards” »

SCHEDULE - M - Revised

How NMPA GMP Promotes Drug Quality and Consistency

Posted on December 14, 2024 By digi

How NMPA GMP Promotes Drug Quality and Consistency How NMPA GMP Promotes Drug Quality and Consistency Introduction to NMPA GMP and Drug Quality The pharmaceutical industry plays a crucial role in public health, providing essential medicines that must meet rigorous standards of safety, efficacy, and quality. In China, the National Medical Products Administration (NMPA), formerly…

Read More “How NMPA GMP Promotes Drug Quality and Consistency” »

NMPA GMP Guidelines

WHO GMP Compliance for Developing Countries: Challenges and Solutions

Posted on December 14, 2024 By digi

WHO GMP Compliance for Developing Countries: Challenges and Solutions Overcoming Challenges and Achieving WHO GMP Compliance in Developing Countries Introduction to WHO GMP Compliance Good Manufacturing Practices (GMP) are essential for ensuring the quality, safety, and efficacy of pharmaceutical products. The World Health Organization (WHO)’s GMP guidelines provide a globally recognized framework for manufacturing medicines,…

Read More “WHO GMP Compliance for Developing Countries: Challenges and Solutions” »

WHO GMP Guidelines

EMA GMP and the Role of Corrective and Preventive Actions (CAPA)

Posted on December 14, 2024 By digi

EMA GMP and the Role of Corrective and Preventive Actions (CAPA) The Critical Role of CAPA in Ensuring EMA GMP Compliance Introduction to Corrective and Preventive Actions (CAPA) Corrective and Preventive Actions (CAPA) are fundamental to achieving and maintaining compliance with the European Medicines Agency (EMA)’s Good Manufacturing Practices (GMP)). CAPA systems are designed to…

Read More “EMA GMP and the Role of Corrective and Preventive Actions (CAPA)” »

EMA GMP Guidelines

The Role of Technology in Achieving ANVISA GMP Compliance in Brazil

Posted on December 14, 2024 By digi

The Role of Technology in Achieving ANVISA GMP Compliance in Brazil The Role of Technology in Achieving ANVISA GMP Compliance in Brazil Introduction to ANVISA GMP and the Role of Technology The pharmaceutical industry in Brazil is governed by stringent regulatory requirements set by the National Health Surveillance Agency (ANVISA). One of the key regulations…

Read More “The Role of Technology in Achieving ANVISA GMP Compliance in Brazil” »

GMP in Latin America (ANVISA, COFEPRIS)

The Role of Corrective and Preventive Actions (CAPA) in MHRA GMP Compliance

Posted on December 14, 2024 By digi

The Role of Corrective and Preventive Actions (CAPA) in MHRA GMP Compliance Understanding the Role of CAPA in Ensuring MHRA GMP Compliance Introduction to Corrective and Preventive Actions (CAPA) Corrective and Preventive Actions (CAPA) are fundamental to maintaining compliance with the Medicines and Healthcare products Regulatory Agency (MHRA) Good Manufacturing Practices (GMP). CAPA systems are…

Read More “The Role of Corrective and Preventive Actions (CAPA) in MHRA GMP Compliance” »

MHRA GMP Guidelines

How TGA GMP Regulations Promote Drug Safety and Consistency

Posted on December 13, 2024 By digi

How TGA GMP Regulations Promote Drug Safety and Consistency Ensuring Drug Safety and Consistency with TGA GMP Regulations Introduction to TGA GMP Regulations The Therapeutic Goods Administration (TGA) enforces Good Manufacturing Practice (GMP) regulations to ensure that pharmaceutical products in Australia are consistently safe, effective, and of high quality. These regulations provide a framework that…

Read More “How TGA GMP Regulations Promote Drug Safety and Consistency” »

TGA GMP Guidelines

How to Integrate PMDA GMP Guidelines into Your Pharmaceutical QMS

Posted on December 13, 2024 By digi

How to Integrate PMDA GMP Guidelines into Your Pharmaceutical QMS How to Integrate PMDA GMP Guidelines into Your Pharmaceutical QMS Introduction to Pharmaceutical QMS and PMDA GMP Guidelines Quality Management Systems (QMS) are essential for ensuring that pharmaceutical manufacturing processes are consistently controlled and that products meet the required quality standards. In Japan, the Pharmaceutical…

Read More “How to Integrate PMDA GMP Guidelines into Your Pharmaceutical QMS” »

PMDA GMP Guidelines

How to Ensure Compliance with WHO GMP Guidelines in Your Facility

Posted on December 13, 2024 By digi

How to Ensure Compliance with WHO GMP Guidelines in Your Facility Ensuring Compliance with WHO GMP Guidelines in Your Pharmaceutical Facility Introduction to WHO GMP Compliance Compliance with the World Health Organization (WHO)’s Good Manufacturing Practices (GMP)) is essential for pharmaceutical manufacturers to ensure the quality, safety, and efficacy of their products. WHO GMP guidelines…

Read More “How to Ensure Compliance with WHO GMP Guidelines in Your Facility” »

WHO GMP Guidelines

Posts pagination

Previous 1 … 39 40 41 … 50 Next

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2026 Pharma GMP.

Powered by PressBook WordPress theme